Annual CFF
$4.13 M
-$15.12 M-78.53%
01 December 2023
Summary:
Actuate Therapeutics annual cash flow from financing activities is currently $4.13 million, with the most recent change of -$15.12 million (-78.53%) on 01 December 2023.ACTU Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$22.32 M
+$21.36 M+2232.37%
01 September 2024
Summary:
Actuate Therapeutics quarterly cash flow from financing activities is currently $22.32 million, with the most recent change of +$21.36 million (+2232.37%) on 01 September 2024. Over the past year, it has increased by +$22.32 million (+100.00%).ACTU Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$27.64 M
+$22.32 M+420.02%
01 September 2024
Summary:
Actuate Therapeutics TTM cash flow from financing activities is currently $27.64 million, with the most recent change of +$22.32 million (+420.02%) on 01 September 2024. Over the past year, it has increased by +$23.50 million (+568.40%).ACTU TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACTU Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -78.5% | +100.0% | +568.4% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ACTU Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -78.5% | at high | at high |
Actuate Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $22.32 M(+2232.4%) | $27.64 M(+420.0%) |
| June 2024 | - | $957.00 K(-78.0%) | $5.31 M(-11.8%) |
| Mar 2024 | - | $4.36 M(>+9900.0%) | $6.03 M(+45.8%) |
| Dec 2023 | $4.13 M | $0.00(0.0%) | $4.13 M(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $0.00(-100.0%) | $4.13 M(0.0%) |
| June 2023 | - | $1.67 M(-32.2%) | $4.13 M(+67.8%) |
| Mar 2023 | - | $2.46 M | $2.46 M |
| Dec 2022 | $19.26 M | - | - |
FAQ
- What is Actuate Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Actuate Therapeutics?
- What is Actuate Therapeutics annual CFF year-on-year change?
- What is Actuate Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Actuate Therapeutics?
- What is Actuate Therapeutics quarterly CFF year-on-year change?
- What is Actuate Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Actuate Therapeutics?
- What is Actuate Therapeutics TTM CFF year-on-year change?
What is Actuate Therapeutics annual cash flow from financing activities?
The current annual CFF of ACTU is $4.13 M
What is the all time high annual CFF for Actuate Therapeutics?
Actuate Therapeutics all-time high annual cash flow from financing activities is $19.26 M
What is Actuate Therapeutics annual CFF year-on-year change?
Over the past year, ACTU annual cash flow from financing activities has changed by -$15.12 M (-78.53%)
What is Actuate Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of ACTU is $22.32 M
What is the all time high quarterly CFF for Actuate Therapeutics?
Actuate Therapeutics all-time high quarterly cash flow from financing activities is $22.32 M
What is Actuate Therapeutics quarterly CFF year-on-year change?
Over the past year, ACTU quarterly cash flow from financing activities has changed by +$22.32 M (+100.00%)
What is Actuate Therapeutics TTM cash flow from financing activities?
The current TTM CFF of ACTU is $27.64 M
What is the all time high TTM CFF for Actuate Therapeutics?
Actuate Therapeutics all-time high TTM cash flow from financing activities is $27.64 M
What is Actuate Therapeutics TTM CFF year-on-year change?
Over the past year, ACTU TTM cash flow from financing activities has changed by +$23.50 M (+568.40%)